| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Across the last three months, Harrow, Inc.'s insiders have reduced their positions by a net 11,250 shares worth roughly $450K.
HROW sits in the Pharmaceuticals industry within the Health Care sector, so this activity is best read against the sector's broader insider trend.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| 10% | 3.68M | $146.05M | - | |
| CEO | 3.00M | $90.48M | - | |
| CFO | 814.7K | $24.36M | - | |
| Dir | 1.0K | $31.1K | - | |
| Dir | 1.0K | $31.0K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 20, 2024 | Opaleye Management Inc.60 | 10% Owner | Buy | 50,600 | $9.65 | $488,290.00 | +1.4% | +67.8% | +167.0% | |
| Nov 16, 2023 | Baum Mark L66 | Chief Executive Officer | Buy | 7,500 | $8.11 | $60,825.00 | +0.4% | +33.6% | +353.6% | |
| Nov 15, 2023 | Opaleye Management Inc.60 | 10% Owner | Buy | 25,000 | $8.03 | $200,735.00 | +0.7% | +42.1% | +429.1% | |
| Sep 20, 2023 | Opaleye Management Inc.60 | 10% Owner | Buy | 20,000 | $14.60 | $292,076.29 | +0.6% | -28.7% | +228.4% | |
| Aug 14, 2023 | Makary Martin A. | Director | Buy | 20,000 | $16.92 | $338,400.00 | +80.0% | -25.8% | +119.0% | |
| Aug 14, 2023 | Baum Mark L66 | Chief Executive Officer | Buy | 5,800 | $17.05 | $98,890.00 | +0.3% | -25.8% | +119.0% | |
| Dec 22, 2022 | Van Horn R. Lawrence | Director | Buy | 1,860 | $13.42 | $24,961.20 | New | +28.0% | -21.6% | |
| Dec 22, 2022 | Boll Andrew R. | Chief Financial Officer | Buy | 2,500 | $13.54 | $33,850.00 | +1.0% | +28.0% | -21.6% | |
| Dec 22, 2022 | Baum Mark L66 | Chief Executive Officer | Buy | 25,000 | $13.39 | $334,750.00 | +1.8% | +28.0% | -21.6% | |
| Dec 21, 2022 | Makary Martin A. | Director | Buy | 25,000 | $13.37 | $334,250.00 | New | +32.6% | -21.6% |